Management of lymph node metastases from an unknown primary site to the head and neck (Review)

Zhuang,Shi  Min; Wu,Xi‑Fu; Li,Jing‑Jia; Zhang,Ge‑Hua

doi:10.3892/mco.2014.361

Management of lymph node metastases from an unknown primary site to the head and neck (Review)

Authors:
- Shi Min Zhuang
- Xi‑Fu Wu
- Jing‑Jia Li
- Ge‑Hua Zhang
View Affiliations

Affiliations: Department of Otorhinolaryngology-Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China
Published online on: July 29, 2014 https://doi.org/10.3892/mco.2014.361
Pages: 917-922

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer of unknown primary site (CUP) is an intriguing clinical phenomenon found in ~3‑9% of all head and neck cancers. It has not yet been determined whether CUP forms a distinct biological entity with specific genetic and phenotypic characteristics, or whether it is the clinical presentation of metastasis in patients with an undetected primary tumor and no visible clinical signs. The treatment of patients with cervical lymph node metastases from CUP remains controversial, due to the lack of randomized clinical trials comparing different treatment options. Consequently, treatment is currently based on non‑randomized data and institutional policy. In the present review, the range and limitations of diagnostic procedures are summarized and an optimal diagnostic work‑up is recommended. The initial preferred diagnostic procedures include fine‑needle aspiration biopsy (FNAB) and imaging. Although neck dissection followed by postoperative radiotherapy is the the most generally accepted approach, other curative options may be used in certain patients, such as neck dissection alone, nodal excision followed by postoperative radiotherapy, or radiotherapy alone. There remains controversy regarding target radiation volumes, ranging from ipsilateral neck irradiation to prophylactic irradiation of all the potential mucosal sites and both sides of the neck. When no primary lesion is identified with imaging and endoscopy in patients without history of smoking and alcohol abuse, molecular profiling of an FNAB sample for human papillomavirus and/or Epstein‑Barr virus is required.

View Figures

View References

1	Pavlidis N, Briasoulis E, Hainsworth J and Greco FA: Diagnostic and therapeutic management of cancer of unknown primary. Eur J Cancer. 39:1990–2005. 2003. View Article : Google Scholar : PubMed/NCBI
2	Strojan P and Anicin A: Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour. Radiother Oncol. 49:33–40. 1998. View Article : Google Scholar : PubMed/NCBI
3	Regelink G, Brouwer J, de Bree R, et al: Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging. 29:1024–1030. 2002. View Article : Google Scholar
4	Issing WJ, Taleban B and Tauber S: Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol. 260:436–443. 2003. View Article : Google Scholar : PubMed/NCBI
5	Grau C, Johansen LV, Jakobsen J, et al: Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol. 55:121–129. 2000. View Article : Google Scholar : PubMed/NCBI
6	D’Souza G, Zhang HH, D’Souza WD, Meyer RR and Gillison ML: Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 46:100–104. 2010.PubMed/NCBI
7	Moncrieff MD, Martin R, O’Brien CJ, et al: Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients? Ann Surg Oncol. 15:3022–3027. 2008. View Article : Google Scholar : PubMed/NCBI
8	Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q and Donald PJ: Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Int J Radiat Oncol Biol Phys. 81:346–352. 2011. View Article : Google Scholar : PubMed/NCBI
9	Coster JR, Foote RL, Olsen KD, et al: Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys. 23:743–749. 1992. View Article : Google Scholar : PubMed/NCBI
10	Glynne-Jones RG, Anand AK, Young TE and Berry RJ: Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. Int J Radiat Oncol Biol Phys. 18:289–294. 1990. View Article : Google Scholar : PubMed/NCBI
11	Weir L, Keane T, Cummings B, et al: Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol. 35:206–211. 1995.PubMed/NCBI
12	Ligey A, Gentil J, Crehange G, et al: Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol. 93:483–487. 2009.PubMed/NCBI
13	Shah JP: Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 160:405–409. 1990. View Article : Google Scholar : PubMed/NCBI
14	Layfield LJ: Fine-needle aspiration in the diagnosis of head and neck lesions: a review and discussion of problems in differential diagnosis. Diagn Cytopathol. 35:798–805. 2007. View Article : Google Scholar : PubMed/NCBI
15	Pfeiffer J, Kayser L and Ridder GJ: Minimal-invasive core needle biopsy of head and neck malignancies: clinical evaluation for radiation oncology. Radiother Oncol. 90:202–207. 2009. View Article : Google Scholar : PubMed/NCBI
16	Martin H and Morfit HM: Cervical lymph node metastasis as the first symptom of cancer. Surg Gynecol Obstet. 78:133–159. 1944.
17	Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F and Ang KK: Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck. 20:674–681. 1998. View Article : Google Scholar : PubMed/NCBI
18	Waltonen JD, Ozer E, Hall NC, Schuller DE and Agrawal A: Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg. 135:1024–1029. 2009. View Article : Google Scholar : PubMed/NCBI
19	Freudenberg LS, Fischer M, Antoch G, et al: Dual modality of ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract. 14:155–160. 2005.
20	Cianchetti M, Mancuso AA, Amdur RJ, et al: Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope. 119:2348–2354. 2009. View Article : Google Scholar
21	Rusthoven KE, Koshy M and Paulino AC: The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 101:2641–2649. 2004. View Article : Google Scholar : PubMed/NCBI
22	Fleming AJ Jr, Smith SP Jr, Paul CM, et al: Impact of [¹⁸F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope. 117:1173–1179. 2007.
23	Wartski M, Le Stanc E, Gontier E, et al: In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun. 28:365–371. 2007. View Article : Google Scholar : PubMed/NCBI
24	Kwee TC and Kwee RM: Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol. 19:731–744. 2009. View Article : Google Scholar : PubMed/NCBI
25	Lee WY, Hsiao JR, Jin YT and Tsai ST: Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck. 22:336–340. 2000. View Article : Google Scholar : PubMed/NCBI
26	El-Mofty SK, Zhang MQ and Davila RM: Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2:163–168. 2008. View Article : Google Scholar
27	Kothari P, Randhawa PS and Farrell R: Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck. Br J Oral Maxillofac Surg. 46:283–287. 2008. View Article : Google Scholar : PubMed/NCBI
28	Waltonen JD, Ozer E, Schuller DE and Agrawal A: Tonsillectomy vs. deep tonsil biopsies in detecting occult tonsil tumors. Laryngoscope. 119:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
29	Koch WM, Bhatti N, Williams MF and Eisele DW: Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 124:331–333. 2001.PubMed/NCBI
30	Mendenhall WM, Amdur RJ, Hinerman RW, et al: Management of the neck including unknown primary tumor. Principles and Practice of Radiation Oncology. Halperin EC, Perez CA and Brady LW: 1. Lippincott Williams and Wilkins; Philadelphia, PA: pp. 1035–1054. 2013
31	Beldi D, Jereczek-Fosa BA, D’Onofrio A, et al: Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Int J Radiat Oncol Biol Phys. 69:1051–1058. 2007. View Article : Google Scholar : PubMed/NCBI
32	Madani I, Vakaet L, Bonte K, et al: Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys. 71:1158–1166. 2008. View Article : Google Scholar : PubMed/NCBI
33	Iganej S, Kagan R, Anderson P, et al: Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck. 24:236–246. 2002. View Article : Google Scholar : PubMed/NCBI
34	Lopez Rodriguez M, Cerezo Padellano L, Martin Martin M and Counago Lorenzo F: Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer. Clin Transl Oncol. 10:812–816. 2008.PubMed/NCBI
35	Erkal HS, Mendenhall WM, Amdur RJ, et al: Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys. 50:55–63. 2001. View Article : Google Scholar
36	Erkal HS, Mendenhall WM, Amdur RJ, et al: Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy with palliative intent. Radiother Oncol. 59:319–321. 2001. View Article : Google Scholar
37	Klop WM, Balm AJ, Keus RB, et al: Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979–1998. Ned Tijdschr Genehieskd. 144:1355–1360. 2000.(In Dutch).
38	Huang CC, Tseng FY, Yeh TH, et al: Prognostic factors of unknown primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 139:429–435. 2008. View Article : Google Scholar : PubMed/NCBI
39	Adelstein DJ, Li Y, Adams GL, et al: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 21:92–98. 2003. View Article : Google Scholar : PubMed/NCBI
40	Bernier J, Domenge C, Ozsahin M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 350:1945–1952. 2004. View Article : Google Scholar : PubMed/NCBI
41	Cooper JS, Pajak TF, Forastiere AA, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 350:1937–1944. 2004. View Article : Google Scholar : PubMed/NCBI
42	Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 349:2091–2098. 2003. View Article : Google Scholar : PubMed/NCBI
43	Vermorken JB, Mesia R, Rivera F, et al: Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
44	de Braud F, Heilbrun LK, Ahmed K, et al: Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment. Cancer. 64:510–515. 1989.PubMed/NCBI
45	Argiris A, Smith SM, Stenson K, et al: Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol. 14:1306–1311. 2003. View Article : Google Scholar : PubMed/NCBI
46	Shehadeh NJ, Ensley JF, Kucuk O, et al: Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck. Head Neck. 28:1090–1098. 2006. View Article : Google Scholar : PubMed/NCBI
47	Pentheroudakis G, Briasoulis E and Pavlidis N: Cancer of unknown primary site: missing primary or missing biology? Oncologist. 12:418–425. 2007. View Article : Google Scholar : PubMed/NCBI
48	Pavlidis N, Pentheroudakis G and Plataniotis G: Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transl Oncol. 11:340–348. 2009. View Article : Google Scholar : PubMed/NCBI
49	Seiwert TY and Cohen EE: Targeting angiogenesis in head and neck cancer. Semin Oncol. 35:274–285. 2008. View Article : Google Scholar : PubMed/NCBI